On the armament and appearances of human myeloid-derived suppressor cells.

作者: Isabel Poschke , Rolf Kiessling

DOI: 10.1016/J.CLIM.2012.06.003

关键词:

摘要: Abstract Myeloid-derived suppressor cells (MDSC) have frequently been observed in patients with cancer. This heterogeneous population of myeloid can exert potent suppression lymphocyte function and thereby poses a significant hurdle to natural or therapeutically induced anti-tumor immunity. On the other hand, MDSC is not yet well understood their role infection, inflammation autoimmune disease still puzzling. Understanding biology will provide tools necessary for therapeutic targeting this population, but also permit exploitation strong tolerogenic treatment inflammatory conditions prevention graft rejection.

参考文章(149)
Yuan Zhang, Limin Cai, Rongcun Yang, Yu Liu, Yinyan Yu, Suguang Yang, Bin Zeng, Zhuohan Zhang, Guohui Jiao, Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells Cancer Immunology, Immunotherapy. ,vol. 58, pp. 687- 697 ,(2009) , 10.1007/S00262-008-0591-5
Paulo C. Rodriguez, David G. Quiceno, Augusto C. Ochoa, l-arginine availability regulates T-lymphocyte cell-cycle progression Blood. ,vol. 109, pp. 1568- 1573 ,(2007) , 10.1182/BLOOD-2006-06-031856
Masaki Terabe, So Matsui, Jong-Myun Park, Mizuko Mamura, Nancy Noben-Trauth, Debra D. Donaldson, Wanjun Chen, Sharon M. Wahl, Steven Ledbetter, Bruce Pratt, John J. Letterio, William E. Paul, Jay A. Berzofsky, Transforming Growth Factor-β Production and Myeloid Cells Are an Effector Mechanism through Which CD1d-restricted T Cells Block Cytotoxic T Lymphocyte–mediated Tumor Immunosurveillance Abrogation Prevents Tumor Recurrence Journal of Experimental Medicine. ,vol. 198, pp. 1741- 1752 ,(2003) , 10.1084/JEM.20022227
Lars C. Jacobsen, Kim Theilgaard-Mönch, Erik I. Christensen, Niels Borregaard, Arginase 1 is expressed in myelocytes/metamyelocytes and localized in gelatinase granules of human neutrophils Blood. ,vol. 109, pp. 3084- 3087 ,(2007) , 10.1182/BLOOD-2006-06-032599
H. van Cruijsen, K. Hoekman, A. G. M. Stam, A. J. M. van den Eertwegh, B. C. Kuenen, R. J. Scheper, G. Giaccone, T. D. de Gruijl, Defective differentiation of myeloid and plasmacytoid dendritic cells in advanced cancer patients is not normalized by tyrosine kinase inhibition of the vascular endothelial growth factor receptor. Clinical & Developmental Immunology. ,vol. 2007, pp. 17315- 17315 ,(2007) , 10.1155/2007/17315
Dmitry I. Gabrilovich, Srinivas Nagaraj, Myeloid-derived suppressor cells as regulators of the immune system Nature Reviews Immunology. ,vol. 9, pp. 162- 174 ,(2009) , 10.1038/NRI2506
Yulia Nefedova, Mayer Fishman, Simon Sherman, Xingyu Wang, Amer A. Beg, Dmitry I. Gabrilovich, Mechanism of All-Trans Retinoic Acid Effect on Tumor-Associated Myeloid-Derived Suppressor Cells Cancer Research. ,vol. 67, pp. 11021- 11028 ,(2007) , 10.1158/0008-5472.CAN-07-2593
V. De Wilde, N. Van Rompaey, M. Hill, J. F. Lebrun, P. Lemaître, F. Lhommé, C. Kubjak, B. Vokaer, G. Oldenhove, L. M. Charbonnier, M. C. Cuturi, M. Goldman, A. Le Moine, Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. American Journal of Transplantation. ,vol. 9, pp. 2034- 2047 ,(2009) , 10.1111/J.1600-6143.2009.02757.X
Susanne Rößner, Constanze Voigtländer, Carsten Wiethe, Jens Hänig, Christian Seifarth, Manfred B. Lutz, Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro European Journal of Immunology. ,vol. 35, pp. 3533- 3544 ,(2005) , 10.1002/EJI.200526172